| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/19/2007 | EP1833964A1 Regulation of metalloprotease cleavage of cell surface proteins |
| 09/19/2007 | EP1833849A2 Fc gamma riib-specific antibodies and methods of use thereof |
| 09/19/2007 | EP1833844A1 Signal peptides, nucleic acid molecules and methods of treatment |
| 09/19/2007 | EP1833510A2 Orally deliverable and anti-toxin antibodies and methods for making and using them |
| 09/19/2007 | EP1833509A2 Delaying or preventing onset of multiple sclerosis |
| 09/19/2007 | EP1833508A2 Porcine reproductive and respiratory syndrome virus strains and compositions |
| 09/19/2007 | EP1833507A1 Compositions for immunizing against mycobacterium |
| 09/19/2007 | EP1833506A2 Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines |
| 09/19/2007 | EP1496907B1 Tyrosine kinase inhibitors |
| 09/19/2007 | EP1349572B1 Manufacturing method of combined vaccine |
| 09/19/2007 | EP1326990B1 Packaging of positive-strand rna virus replicon particles |
| 09/19/2007 | EP1255844B1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 09/19/2007 | EP1190071B1 17867, a novel human aminopeptidase |
| 09/19/2007 | EP1157094B1 Method for the purification, recovery, and sporulation of cysts and oocysts |
| 09/19/2007 | EP1127137B1 Lps with reduced toxicity from genetically modified gram negative bacteria |
| 09/19/2007 | EP1020522B1 Natural human antibody |
| 09/19/2007 | EP0979278B1 Methods for detecting resistance to macrocyclic lactone compounds |
| 09/19/2007 | EP0714438B1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 09/19/2007 | CN101039962A Measuring degree of polymerisation for capsular saccharides that contain sialic acid |
| 09/19/2007 | CN101039960A Chimeric and humanised monoclonal antibodies against interleukin-13 |
| 09/19/2007 | CN101039959A Compositions and methods for treating inflammatory disorders |
| 09/19/2007 | CN101039958A Immunoglobulins comprising predominantly a man3glcnac2 glycoform |
| 09/19/2007 | CN101039955A Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein |
| 09/19/2007 | CN101039951A Liver cancer biomarkers |
| 09/19/2007 | CN101039700A Vaccine conjugate including a human chorionic gonadotropin beta subunit antigen linked to an anti-mannose receptor (mr) antibody |
| 09/19/2007 | CN101039694A Novel therapeutic protein and target e2-epf5 |
| 09/19/2007 | CN101039693A Identifying virally infected and vaccinated organisms |
| 09/19/2007 | CN101039692A Consortium of nitrifying bacteria |
| 09/19/2007 | CN101039691A Compositions and methods for treating neurological disorders |
| 09/19/2007 | CN101037664A Bacterin for pleuropneumonia actinobacillus serotype 1 double-gene deletion mutant without resistance marker |
| 09/19/2007 | CN101037663A Production method for rude type Brucella and its bacterin by using gene recombination technique |
| 09/19/2007 | CN101037478A Rebuild golden staphylococcus enterotoxin N and preparation and application thereof |
| 09/19/2007 | CN101037476A Fusion protein for preparing hepatitis B vaccine and its carrier |
| 09/19/2007 | CN101037475A Chimerical receptor and preparation method and usage |
| 09/19/2007 | CN101036791A Mutans streptococci gene vaccines pcDNA3-pac and the preparing method |
| 09/19/2007 | CN101036790A Protein genetic vaccines on the surface of mutans streptococci and its preparing method |
| 09/19/2007 | CN101036786A Immunomodulation agent with adjuvant having function for treating atherosclerosis |
| 09/19/2007 | CN101036785A Chitosan nanoparticles oral preparations of hepatitis vaccine |
| 09/19/2007 | CN101036784A Toxicity T cell position vaccine of the cell for treating Hepatitis B and the preparing method |
| 09/19/2007 | CN101036783A Method for preparing gram-negative original bacillus having cross-protection power for killing living vaccine |
| 09/19/2007 | CN100338218C Combination neisserial compositions |
| 09/19/2007 | CN100338086C Immunostimulatory nucleic acid molecules |
| 09/19/2007 | CN100337686C Rapid one-step method for generation of antigen loaded dendritic cell vaccine from precursors |
| 09/18/2007 | US7271251 Polyclonal and, or monoclonal antibodies; immuniglobulin immunization |
| 09/18/2007 | US7271248 Polypeptide for therapy of viral infections, cancer, septic shock |
| 09/18/2007 | US7271245 Antibody which specifically binds to an activated alpha v beta 3 integrin receptor which is differentially produced on a cell in a metastatic state, therapy of breast cancer |
| 09/18/2007 | US7271240 Protein for use as diagnostic and therapeutic tool in cancer treatment |
| 09/18/2007 | US7271156 Immunostimulatory nucleic acids |
| 09/18/2007 | US7271151 administering to effect phosphate metabolism in a patient; Metastatic-tumor Excreted Phosphaturic-Element (MERE) or "phosphatonin"; treating X-linked rickets and tumour osteomalacia for example |
| 09/18/2007 | US7271148 Inhibition of cellular proteases |
| 09/18/2007 | US7271144 Therapeutic fibrin-derived peptides and uses thereof |
| 09/18/2007 | US7270997 Genetically engineered attenuated coxsackievirus virion for use as tool in immunotherapy |
| 09/18/2007 | US7270990 Virus production |
| 09/18/2007 | US7270980 Diagnosing prostate cancer in humans; obtain sample, incubate with preferential binding agent, detect bound protein, bound protein indicates prostate cancer |
| 09/18/2007 | US7270960 Diagnosis of ovarian carcinomas |
| 09/18/2007 | US7270955 Detecting modulators of a silencing mediator for retinoic acid receptor; relieving suppression of steroid/thyroid hormone receptor activity; GAL4 DNA binding domains |
| 09/18/2007 | US7270827 For prophylaxis and therapy of microbial infection and eliciting a protective immune response |
| 09/18/2007 | US7270826 Methods of using Botulinum toxin for the treatment of hypervolemic lip deformity (lip ectropion) |
| 09/18/2007 | US7270825 Production of a parvovirus vaccine in plants as viral coat protein fusions |
| 09/18/2007 | US7270821 Hepatitis B core antigen fusion proteins |
| 09/18/2007 | US7270820 Comprise viral amino acid sequences for use in vaccine preparation and prevention of viral infection |
| 09/18/2007 | US7270819 Isolated nucleic acid molecules encoding isolated peptides which correspond to contiguous amino acids of an SSX molecule or NY-ESO-1 and uses thereof |
| 09/18/2007 | US7270818 Treating brain disorder by administering a therapeutically effective amount of antisense oligonucleotide; preventing the formation of Alzheimer senile plaques |
| 09/18/2007 | US7270817 ACPL antibodies and methods of use thereof |
| 09/18/2007 | US7270816 Interleukins; fusion proteins; solid phase synthesis; kits |
| 09/18/2007 | US7270810 Veto cells effective in preventing graft rejection and devoid of graft versus host potential |
| 09/18/2007 | US7270287 Botulinum toxin treatment for kinesia |
| 09/18/2007 | CA2304662C Methods for fabricating polymer-based controlled release preparations |
| 09/18/2007 | CA2276460C Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 09/18/2007 | CA2270952C New use for 1,3-propanediol derivatives |
| 09/18/2007 | CA2185541C Cytotoxic t-cell epitopes |
| 09/15/2007 | CA2579507A1 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof |
| 09/15/2007 | CA2545597A1 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof |
| 09/13/2007 | WO2007103814A2 Angiogenesis pathway gene polymorphisms for therapy selection |
| 09/13/2007 | WO2007103792A2 Methods and compositions for diagnosis and immunotherapy of pollen allergy |
| 09/13/2007 | WO2007103572A2 Extracorporeal removal of microvesicular particles |
| 09/13/2007 | WO2007103565A2 Wnv dna vaccine incorporating a cmv/r backbone and expressing wnv prm and e proteins |
| 09/13/2007 | WO2007103548A2 Novel antibiotic compositions |
| 09/13/2007 | WO2007103470A2 Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 09/13/2007 | WO2007103469A2 Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 09/13/2007 | WO2007103322A2 Compositions that include hemagglutinin, methods of making and methods of use thereof |
| 09/13/2007 | WO2007103225A2 Engineered listeria and methods of use thereof |
| 09/13/2007 | WO2007103112A2 Methods of treating inflammatory and autoimmune diseases with natalizumab |
| 09/13/2007 | WO2007103042A2 Mycoplasma hyopneumoniae vaccine |
| 09/13/2007 | WO2007102802A1 Methods and compositions for poxvirus a35r protein |
| 09/13/2007 | WO2007102583A1 Vaccine for fish, method for producing the same and method for preventing fish infection |
| 09/13/2007 | WO2007102383A1 Methods for damaging cells using effector functions of anti-epha4 antibodies |
| 09/13/2007 | WO2007102326A1 Strong immune induction by using combination of adenovirus type-5/type-35 vector and vaccinia virus mva vector |
| 09/13/2007 | WO2007102230A1 Humanized anti-cd20 monoclonal antibody |
| 09/13/2007 | WO2007102200A1 Anti-cd20 monoclonal antibody |
| 09/13/2007 | WO2007101948A2 Novel vaccines for treating or preventing infections by parasites of the family taenidae and in particular of the genus echinococcus |
| 09/13/2007 | WO2007101657A1 Hepatitis c virus non structural fusion protein |
| 09/13/2007 | WO2007101441A1 Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections |
| 09/13/2007 | WO2007101347A1 Bir domain binding compounds |
| 09/13/2007 | WO2007101337A1 Methods and compositions comprising bacterial type hi secreted proteins for mucosal immunization of animals |
| 09/13/2007 | WO2007101332A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and ovarian cancer |
| 09/13/2007 | WO2007101331A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and prostate cancer |
| 09/13/2007 | WO2007087457A3 Combination therapy for the treatment of neovascular disorders |
| 09/13/2007 | WO2007087367A9 Methods and compositions for modulating the mobilization of stem cells |
| 09/13/2007 | WO2007086932A3 Prostate stem cell antigen vaccines and uses thereof |